2025 Major Co-Funding Grant Round for Mitochondrial Disease Research
The Mito Foundation and the United Mitochondrial Disease Foundation (UMDF) have joined forces to launch a transformative analysis funding alternative. The 2025 grant spherical provides as much as US$500,000 for major mitochondrial illness analysis.
This landmark collaboration builds on a robust partnership and former co-funding success since 2016. By combining the experience and assets of those two main organizations, they intention to maximise the affect for the mitochondrial illness (mito) group. This joint effort represents a daring funding in advancing progressive analysis and scientific breakthroughs that tackle the urgent wants of people residing with mito.
Grant Details and Key Information
Applications for this grant spherical are open to researchers worldwide and might be evaluated based mostly on their potential to ship significant outcomes for the mito group.
Important Dates:
- Grant purposes open: 31 January 2025, 9am EST / 1 February 2025, 1am AEDT
- Grant purposes shut: 28 February 2025, 5pm EST / 1 March 2025, 9am AEDT
- Outcomes announcement: June 2025
- Project begin date: As early as September 2025, pending grant award settlement execution
Leadership Remarks
Sean Murray, CEO of the Mito Foundation, emphasised the importance of this collaboration:
“Mito Foundation and UMDF share a deep history of collaboration based on trust and mutual respect. By coming together, we can champion the best primary mitochondrial disease research and clinical work. I am confident that this partnership will accelerate critical advancements, offering hope and tangible benefits for those affected by mito, now and into the future.”
Kristen Clifford, CEO of UMDF, echoed these sentiments:
“UMDF has always been committed to funding the best science in the world, no matter where it’s found. This collaboration reinforces that this is a global effort. We thank The Mito Foundation for their partnership to help fund the research that will chart the path toward treatments, and eventually cures, for mitochondrial disease patients.”
How to Apply
Researchers on this funding alternative ought to learn the Request for Proposals (RFP) for detailed info on the scope, funding mechanisms, application course of, and overview course of.
Steps to Apply:
- Read the Request for Proposals to know the scope and necessities.
- Submit an application by means of the UMDF Online Grant Portal.
- Grant purposes shut: 28 February 2025, 5pm EST / 1 March 2025, 9am AEDT
Contact Information: For any inquiries, please electronic mail grants@umdf.org.
This partnership underscores their shared dedication to driving progress within the discipline of mitochondrial medication to make an actual difference in individuals’s lives. Together, they will chart the trail towards therapies and ultimately cures for mitochondrial illness sufferers.
Apply now and be a part of this transformative research funding opportunity!
Related
2025 Major Co-Funding Grant Round for Mitochondrial Disease Research
